Improvement in Gemcitabine-Induced Thrombotic Microangiopathy with Rituximab in a Patient with Ovarian Cancer: Mechanistic Considerations.

Murugapandian, Sangeetha; Bijin, Babitha; Mansour, Iyad; Daheshpour, Sepehr; Pillai, Biju G; Thajudeen, Bijin; Salahudeen, Abdulla K

Murugapandian, Sangeetha; Bijin, Babitha; Mansour, Iyad; Daheshpour, Sepehr; Pillai, Biju G; Thajudeen, Bijin; Salahudeen, Abdulla K.

Afiliação

Murugapandian S; Department of Nephrology, University of Arizona Medical Center, Tucson, Ariz., USA.
Bijin B; Department of Nephrology, University of Arizona Medical Center, Tucson, Ariz., USA.
Mansour I; Department of Medicine, University of Arizona Medical Center, Tucson, Ariz., USA.
Daheshpour S; Department of Medicine, University of Arizona Medical Center, Tucson, Ariz., USA.
Pillai BG; Department of Nephrology, University of Arizona Medical Center, Tucson, Ariz., USA.
Thajudeen B; Department of Nephrology, University of Arizona Medical Center, Tucson, Ariz., USA.
Salahudeen AK; Department of Nephrology, University of Arizona Medical Center, Tucson, Ariz., USA.

Case Rep Nephrol Dial ; 5(2): 160-7, 2015.

Article em En | MEDLINE | ID: mdl-26266248

Palavras-chave

Gemcitabine; Ovarian cancer; Rituximab; Thrombotic microangiopathy

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Case Rep Nephrol Dial Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google